MedPath
NMPA Approval

Pretomanid Tablets

国药准字HJ20240153

December 1, 2024

Drug Information

普托马尼片

片剂

200mg

化学药品

December 1, 2024

November 30, 2029

Company Information

Applicant Company

Newenham Court, Northern Cross, Dublin 17, Dublin IRELAND

Manufacturing Company

(FDF-2) H-12&H-13, MIDC, Waluj, Aurangabad, Maharashtra 431136 INDIA

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

普托马尼片 - NMPA 批准文号 | MedPath